Opinion
Video
Author(s):
Panelists discuss how novel treatment mechanisms, efficacy assessments, and improved patient engagement strategies are shaping the evolving landscape of vitiligo management.
Upadacitinib Shows Biomarker-Driven Efficacy in Nonsegmental Vitiligo
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD
Vitiligo in Clinical Practice: Expert Insights on Diagnosis, Comorbidities, and Treatment
ReV Up Your Vitiligo Treatment Strategies
Patients with DIMIDs and Pandemic Risks
Topical TCA and Methoxsalen Not Clinically Effective for Acral Vitiligo